@article{0f263cb6c40241d6bd56f66044217a9d,
title = "Can early intervention with pharmacotherapy reduce the morbidity and mortality of chronic lymphocytic leukemia?",
keywords = "CLL early intervention, asymptomatic CLL, early stage CLL",
author = "Shuo Ma and Platanias, {Leonidas C.}",
note = "Funding Information: S Ma has received research funding from AbbVie, Acerta, Gilead Sciences, Pharmacyclics and Xeme Biopharma, honoraria for advisory board participation from AbbVie, Genentech, Gilead Sciences, Pharmacyclics and Janssen Pharmaceuticals. S Ma has also received speaker fees from Genentech and Pharmacyclics. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.",
year = "2018",
month = jul,
day = "24",
doi = "10.1080/14656566.2018.1498844",
language = "English (US)",
volume = "19",
pages = "1171--1175",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "11",
}